2018 年 7 月 26 日 Certara Experts Highlight Quantitative Systems Pharmacology’s Role in First-in-human Clinical Trials
2018 年 6 月 14 日 Certara Supports the Not-for-profit Biotechnology Company Medicines Development for Global Health (MDGH) on the FDA New Drug Approval of Moxidectin for the Treatment of River Blindness (Onchocerciasis), a Neglected Tropical Disease
2018 年 6 月 5 日 Certara Launches Version 8.1 of its Industry-leading Phoenix PK/PD Modeling and Simulation Software; Introduces Professional Certification Program
2018 年 5 月 29 日 Certara Scientists to Present Model-informed Drug Development, Systems Pharmacology and MBMA Advances at PAGE 2018
2018 年 4 月 12 日 Certara Acquires Analytica Laser, a Leader in Market Access, Health Economics and Outcomes Research (HEOR), and Real-world Evidence Solutions
2018 年 3 月 13 日 Certara Launches Industry-first Quantitative Systems Pharmacology (QSP) Consortium on Immuno-oncology with Leading Pharma Company Members
2018 年 3 月 12 日 Certara and Faculty from UNC Eshelman School of Pharmacy to Launch New Pharmacometrics Skills Competition at ASCPT 2018 Annual Meeting
2018 年 2 月 14 日 Certara Launches Version 10 of D360, Its Industry-leading Drug Discovery Informatics Platform